GE Healthcare announced that the U.S. Food and Drug Administration (FDA) has approved a label change for the ultrasound contrast agent Optison (Perflutren protein-Type A Microspheres Injectable Suspension, USP). The FDA removed the contraindications for use in patients with cardiac shunts and for administration by intra-arterial injection. Both contraindications have been revised and moved to the WARNINGS AND PRECAUTIONS section (5.3 : Systemic Embolization) of the Full Prescribing Information.

Ask anyone from Pokemon Go players to BlackBerry diehards. Smartphones have a lot to offer. That potential may be expressed in high-tech apps or decidedly low-tech speech. 

breast density, inform laws
breast density
breast density, mammography
breast density, cancer

The internet and social media have transformed our lives. It has literally opened up a global connection to those with similar interests and passions. In my focused world of patient advocacy for breast health, I meet innumerable women, fervent in their yearly breast cancer screening yet diagnosed with a missed, delayed and advanced stage cancer because of their dense breast tissue. Like me, these women never knew about the impact of dense breast tissue on the reliability of their mammogram until after their diagnosis. Our mission is to correct this fatal flaw in breast cancer screening.

Mammography has long been considered the gold standard for breast cancer detection, acting as the first line of defense for millions of women every year in hopes of catching cancer early. The true efficacy of the modality has come into question in recent years, however, due to increased understanding about the impact of dense fibroglandular breast tissue on screening. This has led to the emergence and/or increased use of other modalities in an effort to improve cancer detection rates above what is currently capable with mammography.
marketing, blog

With today’s widespread internet-savvy, purchasers will most likely research a product online first. Modern medical technology is an investment, so a lot of thought and research is put into the decision-making process. Short from buying the actual equipment itself, potential purchasers will scour the internet for product reviews and industry certifications. This word-of-mouth form of advertising is often one of the most reliable yet hardest to recover from, so always be aware of online reviews and feedback.

"The industry standard of imaging system availability is 99.999 percent uptime, but that’s not good enough for Broward Health. Our vendor neutral archive (VNA) is a critical system in our enterprise imaging environment. It serves as the brains of our operation, supporting a variety of clinical customers within high acuity settings. Broward Health Medical Center is a Level I Trauma Center where every minute counts. We need zero downtime.” 

voice technology

The last two decades have brought a series of changes in medicine, technology and healthcare legislation that have impacted the field of diagnostic imaging and the role of the radiologist. Coupled with these changes, imaging volume is declining1 due to costs as well as concerns over patient radiation exposure.2 This environment often makes it challenging for radiology groups to protect their financial performance and ensure they deliver high-quality studies and readings. Fortunately, advances in imaging and information technology have emerged, helping radiologists increase the utilization of diagnostic imaging and moving the radiologist into a more central role in integrated patient care.3

Asante Health System provides comprehensive medical care to more than 580,000 people throughout Southern Oregon and Northern California. As the largest healthcare provider in nine counties, Asante knew seamlessly sharing patient information with affiliates would be key to better physician relationships and improved patient outcomes.  

PET imaging
PET imaging

Precision medicine is not only a buzzword, it is a call to action to radically advance our capabilities in the era of molecular targeted medicine. Positron emission tomography (PET) has firmly established its leading role as a capable oncologic molecular imaging technique over the last two decades, however its technological advances have been modest at best.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now